Get started
Author

Mathieu Boucher

Observed names: Boucher, Mathieu, M Boucher
ORCID: 0000-0003-3403-7912
Observed ORCID: 0000-0003-3403-7912
OpenAlex ID: A5058776053
Neuroprotective effects of M826, a reversible caspase‐3 inhibitor, in the rat malonate model of Huntington's disease
2004 · Sylvie Toulmond, Keith Tang, et al. · British Journal of Pharmacology · 56
PDF
Tau-mediated process outgrowth is differentially altered by the expression of MAP2b and MAP2c in Sf9 cells
1999 · Mathieu Boucher, Dave B�langer, et al. · Cell Motility and the Cytoskeleton · 19
Flexibility as a marker of early cognitive decline in humanized apolipoprotein E ε4 (ApoE4) mice
2021 · Julien Schmitt, Anne-Lise Paradis, et al. · Neurobiology of Aging · 6
Tacrolimus ointment for the treatment of atopic dermatitis.
2001 · M Boucher · PubMed · 3
Abstract B029: Forging strong bidirectional preclinical and translational research for optimized drug development of Sym023 (S095018), a novel anti-TIM3 antibody
2025 · Julia Geronimi, Aditi Varthaman, et al. · Cancer Immunology Research · 1
Preclinical characterization of S095029, a novel clinical-stage Fc-attenuated NKG2A-blocking antibody for cancer immunotherapy
2026 · Maria Carlsen Melander, Franziska Uhlenbrock, et al. · Frontiers in Oncology
PDF
Validation of memory assessment in the Starmaze task: Data from 14 month-old APPPS1 mice and controls
2021 · Julien Schmitt, Anne-Lise Paradis, et al. · Data in Brief
PDF
Works count: 8
Citation count: 85
H-index: 3
I10-index: 2
Year
Topic
Type